A novel series of azolylalkyloxy compounds was designed, synthesized and evaluated for antipicornaviral activity. Several of the compounds exhibited in vitro activity comparable to that of Disoxaril. An investigation of qualitative structure-activity relationships indicated that the optimal length of the alkyl chain is six or seven carbon atoms, with seven being marginally superior. The effect of different azole moieties on activity was relatively small, with 3-methylisoxazole and 4-methylthiazole being most effective. The nature of the oxy substituent was found to be extremely important for antipicornaviral activity. The 2-dibenzofuryl group proved to be the most effective oxy substituent for this class of compounds. Compounds 11 and 22, combining dibenzofuran with 3-methylisoxazole and 4-methylthiazole, respectively, were highly effective in vitro against a wide range of human rhinoviruses as well as several enteroviruses.
Introduction
The picornaviruses, which comprise the rhino-and enteroviruses, are responsible for a multitude of diseases in man. The over 100 serotypes of human rhinovirus (HRV) are responsible for mild respiratory tract ailments and approximately half of the cases of the common cold. Enteroviruses, which include polioviruses, echoviruses, coxsackieviruses A and B and hepatitis A, are the cause of such conditions as poliomyelitis, viral meningitis, hepatitis A, and various upper respiratory infections. There therefore exists a need for effective broad-spectrum chemotherapeutic agents for picornavirus infections.
Arildone 1 is a compound that was found to be orally effective in mice infected with polio-2 (McKinlay et al., 1982) . It was not highly effective against the rhinoviruses, however, which motivated the study of structurally related compounds. A series of isoxazoles was synthesized from which several agents with broad-spectrum activity against both rhinoviruses and enteroviruses were obtained (Diana et al., 1985a) . Further modification resulted in the discovery of Disoxaril 2 which exhibited marked efficacy against a variety of picornaviruses both in vitro and in vivo (Diana et al., 1985b) . Numerous analogues of Disoxaril have been prepared and detailed structure-activity relationships elucidated (Diana et al., 1987 (Diana et al., , 1988 (Diana et al., , 1990 (Diana et al., , 1992 (Diana et al., , 1993 .
In addition, the three-dimensional crystal structure of HRV-14 has been determined (Rossman et al., 1985) . Of particular interest is the presence of 'canyons' on the viral capsid surface. These canyons are believed to be the site of cell receptor-mediated binding. X-ray crystallography of the HRV-14/Disoxaril complex showed that Disoxaril and related compounds bind reversibly to a hydrophobic pocket beneath the base of the canyon. This pocket is reached via a pore that is present on the canyon floor (Smith et el., 1986) . Upon binding, these compounds inhibit uncoating of the virion after it has penetrated the cell membrane thus blocking viral replication (Diana et al., 1985b) . More recently, it has been reported that several Disoxaril analogues inhibit adsorption of HRV-14 to the host cells, indicating a different mode of action for certain members of this series of compounds (Pevear et et., 1989). In the light of the lack of drugs available for the treatment of picornavirus infections and what was known about the binding site for the arildone-related compounds, we designed, synthesized and evaluated a series of azolylalkyloxy compounds with the goal of discovering novel, broad-spectrum antipicornavirus agents.
Results

Chemistry
The procedure for the synthesis of azolylalkyl bromides was similar to a previously reported method (Diana et al., Table 2 . D = K 2COJacelone/reflUx; E = K 2COJDMF/reflux; F = Nalbenzene/reflux; G = NaNHiloluene/reflux. ) and is shown in Fig. 1 . Lithiation of optionally substituted azoles 3 with lithium diisopropylamide (LOA) or nbutyllithium (n-BuLi) at -70°C in tetrahydrofuran (THF) (Micetich, 1970; Micetich et al., 1985) followed by reaction with a large excess of a dibromoalkane 4 resulted in the azolylalkyl bromides 5 in yields of 20 to 50%. Imidazole was bromoalkylated in 50% yield by refluxing with a dibromoalkane in THF in the presence of potassium carbonate. The results are summarized in Table 1 .
As indicated in Fig. 2 , alkylation of various hydroxy compounds 6 was typically achieved by treatment with an azolylalkyl bromide 5 in the presence of potassium carbonate in refluxing acetone or N,N-dimethylformamide (OMF), Alcohols of particularly weak acidity required the use of stronger bases in order for alkylation to occur. In the case of 9-hydroxyfluorene, reaction with metallic sodium in dry, refluxing benzene was necessary, while an excess of sodamide in dry, refluxing toluene was required for the alkylation of 1-adamantanol. Yields ranged from 15 to 81% for the alkylation reactions. The resulting azolylalkyloxy compounds 7-45 are listed in Table 2 .
Biology
The compounds were initially screened against two rhinovirus serotypes (HRV-1A and HRV-39) using a cytopathic effect inhibition method and a dye uptake assay to determine their MIC so values ( Table 2 ). The toxicity was evaluated by noting the concentration at which cell viability was reduced by 50% as compared to cell controls, and reported as TD so values. Eight of the compounds tested (11, 14, 15, 22, 25, 27, 31 and 37) which exhibited activity comparable to that of Disoxaril (MIC so values s 10 f..lg mr")
were selected for further study. The active compounds chosen were evaluated against a panel of 20 rhinovirus serotypes in order to determine more accurately their range of activity ( In addition, seven of the compounds (11,14,15,22,25, 27 and 31) were tested against a panel of enteroviruses to give an indication of their spectrum of activity (Table 5) . Compounds 11 and 22 were found to be active against 5 and 6 of the 7 enteroviruses of the panel, respectively.
MIC so values ranged between 1 and 25 f..lg rnr",
Molecular modelling
The structure of an HRV-14 complex with the antiviral agent WIN V (S) was obtained from the Protein Data Bank (Chemistry Department, Brookhaven National Laboratory, Upton, NY). All residues more than 30 Afrom the inhibitor were removed, hydrogen atoms were added, and minimization was performed. The active site was further refined by minimization of the inhibitor and all residues within approximately 12 A. The resultant conformation of WIN V (S) in the active site was used as a template onto which various structures from Table 2 were forced. The resulting protein/inhibitor complexes were then refined as above.
Interestingly, all of the structures, including the very bulky dibenzylamino compound (10), could be accornodated within the binding pocket. It should be noted, how- ever, that the compounds were placed in the pocket, and thus there was no consideration of the degree of difficulty of access to the active site. It is possible that this factor plays a major role in determining biological activity.
Discussion
It was previously determined that Disoxaril analogues orient themselves in the binding pocket in two ways (Diana et al., 1990) . Compounds with a five-carbon bridge were oriented with the isoxazole positioned below the pore and the oxy substituent in the 'toe' of the pocket. In addition, some compounds with a seven-carbon bridge were oriented in the same way. However, analogues with a seven-carbon bridge and additional bulk on the oxy substituent (in the form of alkyl groups) were found to orient in the opposite direction, with the oxy substituent below the pore and isoxazole in the 'toe'. Since crystallographic data for our compounds has not been obtained, and therefore the exact orientation each compound adopts in the active site is not known, elucidation of structure-activity relationships is complicated considerably.
It was previously reported that a chain length of seven carbon atoms was optimal for antiviral activity (Diana et et., 1990) . For this study, all but one of the compounds synthesized had chains of six or seven carbon atoms. Compounds 22 and 25, which differed only in that their chain lengths were seven and six carbons, respectively, exhibited very similar activities against the rhinoviruses. However, 22 was more effective against the enteroviruses, implying that a seven-carbon chain is superior for broadspectrum activity. Not surprisingly, compound 33 with a chain length of three was completely inactive. The effect of the azole moiety was found to be relatively minor in the group of azoles used in this study. Significant activity was exhibited by compounds containing each of the azoles. In comparison to similar analogues, compounds NA  25  56  5  3  3  5  10  18  14  NA  NA  3  5  NA  <0.5  58  5  3  5  10  5  5  15  5  3  5  9  8  3  59  10  5  7  10  10  10  16  1  3  3  5  3  1  61  5  0.5  5  5  5  5  17  10  NA  5  17  10  <0.5  62  NA  NA  10  NA  NA  NA  18  15  3  25  NA  18  10  63  10  3  NA  17  5  18  20  15  3  17  NA  10  5  64  NA  NA  NA  NA  10  10  21  5  1  10  10  5  5  65  NA  NA  NA  NA  NA  NA  22  10  3  5  10  5  10  66  NA  NA  NA  NA  NA  25  23  3  2  8  3  3  8  67  NA  NA  NA  NA  NA  NA  25  10  5  10  25  10  12  68  NA  NA  NA  NA  NA  NA  28  25  10  NA  NA  25  10  69  NA  NA  10  NA  NA  5  29  5  3  3  25  3  8 MIC so (l1g ml-')" containing the 3,5-dimethylpyrazol-1-yl moiety (34-36) and the imidazol-1-yl moiety (44,45) tended to be either more toxic or less active and therefore were deemed unsuitable for further study.
Within the series of compounds incorporating 3-methylisoxazole, 4-methylthiazole, 4-methylisothiazole or isothiazole,there was a relatively small difference in antiviral activity associated with the different azoles. For example, when the 2-dibenzofuryloxy analogues of these azoles (11, 22, 27 and 31) were compared, only small differences in MIC so values were observed. Even the more polar and significantly bulkier 1-phenylpyrazol-5-yl moiety resulted in active compounds (37,38), but its 4-chloro analogues showed decreased activity.
Overall, the 3-methylisoxazol-5-yl moiety had marginally superior antirhinoviral activity, and compound 11 was also active against five of seven enteroviruses tested. In addition, the 3-methylisoxazol-5-yl compounds generally exhibited lower toxicity. The 4-methylthiazol-2-yl moiety also resulted in compounds with good broad-spectrum activity against both rhinoviruses and enteroviruses. [n general, however, large differences in activity were not observed when the azole moiety was varied.
The most significant findings in this study were in relation to the oxy substituent. Within an analogous series of compounds, MIC so values could vary between 1 and > 100 f.lg ml-1 depending on the nature of the oxy substituent. For example, consider the 1-(3-methylisoxazol-5-yl)-7-oxyheptyl series (compounds 7-21). The dibenzylamino compound (10) was completely inactive. There are two plausible explanations for this. Binding of these types of compounds is largely a result of hydrophobic interactions. Steric or Van der Waal's interactions are generally the most important factor for biological activity. Although bulk is important, the nature of the binding pocket imposes limits on the amount of bulk and how it is oriented. Even though modelling showed that 10 could be accommodated within the binding pocket, it has been proposed that for Disoxaril and its analogues excessive bulk in the phenyl region of the inhibitor leads to decreased activity (Diana et al., 1992) . Our modelling experiments indicated that the dibenzyl group is located in what would be the phenyl region of Disoxaril. In the case of 10, it seems likely that certain spatial limits are exceeded. A second possible explanation relates to the theory that major conformational changes of the capsid protein must occur during the entry of an inhibitor to the binding pocket (Diana et el., 1992) . If this is the case, then steric factors may prevent or inhibit a compound such as 10 from even reaching the active site because of the large conformational changes that would be necessary during its passage thereto. Similar arguments could be made for other inactive compounds in this series. The 1-adamantanyl derivative (18) was synthesized as an example with a bulky, hydrophobic substituent that displays purely Van der Waal's type interactions. While this compound showed moderate activity, it was not among the most effective. The steric factors discussed above could also apply in this case. In addition, it was reported that in some Disoxaril analogues the phenyl ring appeared to be in a stacking configuration with Tyr 12 8 and Tyr 1S2 of the capsid protein (Diana et al., 1992) . Such pitype interactions may contribute to activity, and in the case of 18 such an interaction is obviously not possible. Weak activity was observed for the 1-and 2-naphthyl derivatives (19 and 20) . One can speculate that perhaps these moieties do not provide quite enough steric bulk and Van der Waal's interactions to produce highly active compounds.
The 2-methylquinolin-4-yl analogue (15) demonstrated excellent activity against the rhinoviruses. Consistently low MIC so values were associated with this substituent when combined with the majority of azoles used in this study. Unfortunately, 15 did not show any activity against the enteroviruses, and several other compounds containing the 2-methylquinolin-4-yl moiety (28, 32 and 42) exhibited significant toxicity. Such factors limit the potential for further development of these compounds. The moiety that uniformly led to highly active analogues was the 2-dibenzofuryl group. Compounds 11, 22, 25, 27, 31 and 37, which combined the 2-dibenzofuryl moiety with a variety of azoles, all had MIC so values comparable or superior to Disoxaril while also displaying low toxicity.
Compounds 11 and 22 were effective against most of the rhinoviruses and enteroviruses tested and were the most promising analogues synthesized. The 2-dibenzofuryl group seems to fulfill best both the steric and hydrophobic requirements of the binding pocket.
When compared to compound 11, the 2-carbazolyl analogue 14 was only marginally less active against rhinoviruses, but inactive against the enteroviruses. The fact that carbazole is slightly less hydrophobic than dibenzofuran may at least partially account for this observation. Compound 13, with a 9-fluorenyl substituent, showed only slight activity when compared to structurally similar 11 and 14. Since 11 and 14 (2-dibenzofuryl and 2-carbazolyl respectively) differ from 13 mainly in the position of attachment on the substituent, it seems likely that the fluorene, attached at the 9-position, is oriented unfavourably in the binding pocket. Modelling showed that the 2-dibenzofuryl and 2-carbazolyl moieties are arranged in a somewhat linear configuration with respect to the carbon chain. In contrast, the 9-f1uorenyl group is oriented in a more perpendicular configuration with respect to the carbon chain, which results in considerable bulk in what corresponds to the phenyl region of Disoxaril. As discussed previously, such a situation generally leads to poor biological activity.
A number of highly active azolylalkyloxy antipicornaviral compounds have been synthesized. In order for these compounds to be effective, certain structural requirements must be fulfilled. The length of the carbon chain' should be six or seven atoms, with seven being ideal. The azole moiety can be varied, with relatively small hydrophobic groups such as 3-methylisoxazole or 4-methylthiazole being optimal. Selection of the bulky oxy substituent is crucial. It must be hydrophobic in nature and effectively fit the binding pocket. The 2-dibenzofuryl moiety was the substituent that best met these criteria during this study.
Materials and Experimental Procedures: Virology
The experiments were performed by a cytopathic effect inhibition method and a crystal violet dye uptake assay. Wis HeLa cells were obtained from Sterling Winthrop. Picornaviruses were from ATCC. Minimum Essential Medium (MEM) was Eagle's (modifiedwith Earles salt) supplementedwith 5% newborn calf serum, 100Lu.ml-1 penicillin G, 100llgml-1 streptomycin, 290Ilg mF 1 L-glutamine, and 0.09% sodium bicarbonate. Basel EssentialMediumwas Eagle's (modifiedwith Earles salt) supplemented with 2% fetal calf serum and antibiotics as MEM. Plateswere Falcon,96 well, Model 3072.
Stock cell cultures were prepared in the 5% newborn calf MEM. Drugswere dissolvedin DMSOto 20 mg rnl" and further diluted in the 2% fetal calf MEM. 50 III of each sample dilution were added to duplicate wells. 50111 of 100 TCID so virus in 2% fetal calf serum MEM was added to all the wells except the cell control and drug control wells. 100III of 2% fetal calf serum MEM containing 3.5x 105 HeLa cells rnr" was added to all the wells.The plates were incubated at 33 DC, 2% CO 2 and were visually read when the virus controls show 100% cytopathic effect (typically3-6 days). MIC so refers to 50% inhibition of cell death, and TD so to 50% reduction of cell viability as compared to respectivecontrols.
The cells were then fixed with 20 III of 25% glutaraldehyde for 15 min, washed with water and dried. They were then stained with 100III of 0.05% crystal violet for 15 min, washed with water and dried. The cells were then eluted with 100III of Lyser buffer (0.05M NaH2P04!ethanol 1:1 v!v), shaken and read at OD 540+450nm on a multiscan spectrophotometer. The results of the cytopathic effect inhibition method and the dye uptake assay were generally identical. If not, the higher of the two values is cited.
Materials and Experimental Procedures: Molecular Modelling
Computational results were obtained using software programs from Biosym Technologies (San Diego). Molecular mechanics calculations were carried out with the Discover program, using the CVFF forcefield. The Insight II molecular modelling system was used to view the results.
Materials and Experimental Procedures: Chemistry
Melting points were determined on an Electrothermal digital melting point apparatus and are uncorrected. NMR spectra were aquired on a Bruker AC-E 200 FTNMR. Elemental analyses were performed by the Chemistry Department of The University of Alberta (Edmonton, Alberta, Canada). DMF and acetone were distilled over calcium hydride and stored over molecular sieves. THF was distilled from sodium benzophenone ketyl. The silica gel used was Kieselgel 60, 230-400 mesh (Merck).
Method A: 7-(3-methylisoxazol-5-yl) 
heptyl bromide (Sa)
To a solution of diisopropylamine (8.4 ml, 0.06 mol) in THF under nitrogen, was added, at -5 DC, n-butyllithium (1.6 M in hexane, 37.5ml, 0.06 mol). After the addition was complete, the solution was cooled to -70 DC and 3,5-dimethylisoxazole (5.82g, 0.06 mol) in 20 ml THF was added dropwise. The mixture was stirred for an additional hour at -70 DC, then added via nitrogen purge to a stirred solution of 1,6-dibromohexane (58.56g, 0.24 mol) in 40 ml THF at -70 DC. The mixture was allowed to warm to room temperature and stirred overnight.
After quenching with 30 ml saturated NH 4CI, the mixture was extracted with 250 ml CH 2CI2 . The organic extract was washed with brine and dried over anhydrous sodium sulfate, and the solvent was evaporated. Excess 1,6-dibromohexane was distilled off under reduced pressure and the residue purified by elution through a silica gel column using ethyl acetate/hexane (1:4 v/v) as eluent to give 9.20 g (59"10) of sa as a pale yellow oil. B: 6-(1-phenylpyrazol-5-yl) hexyl bromide (Sh) n-BuLi (1.6 M in hexane, 27.3 ml, 43.8 mmol) was added to a solution of 1-phenylpyrazole (6.0 g, 41.7 mmol) in 40 ml THF at -70 DC and under nitrogen. The mixture was stirred for 5 h at this temperature and then added via nitrogen purge to a solution of 1,6-dibromohexane (40.7g, 166.8 mmol) in 40 ml THF, also at -70 DC. The mixture was allowed to warm to room temperature and then stirred overnight. Following work-up and purification as in Method A, 6.4 g (50%) of 5h was obtained as a yellow oil.
Method
Method C: 6-(imidazol-1-yl)hexyl bromide (5j)
A mixture of imidazole (2.72g, 0.04 mol), K 2C03 (6.62g, 0.05 mol) and 1,6-dibromohexane (11.71 g, 0.05 mol) in 40 ml THF was heated to reflux for 3.5 h. The mixture was filtered and the solvent evaporated. Elution through a silica gel column using methanol/chloroform (1:20 vlv) gave 4.62 g (50%) of 5h as a pale yellow oil. This compound was quite unstable and was used immediately for further reaction.
Using Methods A, Band C, compounds 5a-j as indicated in Table 1 were prepared. 0: 5-[7-[4-(imidazol-1-yl) phenoxy]heptyl]-3-methylisoxazole (7) 5a (0.52 g, 2.0 mmol) was added to a mixture of p-{imidazol-1-yl) phenol (0.32 g, 2.0 mmol) and K 2C03 (0.28 g, 2.0 mmol) in 20 ml anhydrous acetone with stirring. The reaction was heated to reflux for 27 h, then cooled and filtered. The acetone was evaporated and the residue dissolved in 30 ml CH 2CI2 and washed sequentially with 3 portions water, 5% KOH, and 3 more portions of water. After drying over sodium sulfate and evaporation of the solvent, the resulting crude compound was purified by elution through a silica gel column using methanol/hexane/ethyl acetate (1:3:7 v/v) as eluent to give 0.34 g (50%) of 7 as a pale yellow solid. E: 5-[7-[(carbazol-2-yl) (14) 5a (0.52 g, 2.0 mmol) was added to a mixture of 2-hydroxycarbazole (0.37 g, 2.0 mmol) and K 2C03 (0.35 g, 2.5 mmol) in 15 ml anhydrous DMF with stirring. The reaction was heated to reflux for 3 h and then cooled. The DMF was distilled at reduced pressure and the residue dissolved in 30 ml CH 2Cl2 and washed sequentially with 3 portions water, 5% KOH, and 3 more portions of water. After drying over sodium sulfate and evaporation of the solvent, the resulting crude compound was Antipicornaviral azolylalkyloxy compounds 253 purified by elution through a silica gel column using dichloromethane as eluent to give 0.15g (20%) of 14 as a colourless solid. F: 5-[7-[(f1uoren-9-yl) 
Method
oxy]heptyl]-3-methylisoxazole (13)
Metallic sodium (0.05 g, 2.0 mmol) was added to a solution of 9-hydroxyfluorene in anhydrous benzene (10 ml) and the mixture heated to reflux for 2 h. 5a was then added and the reaction heated to reflux overnight. The solution was cooled and the solvent evaporated. The residue was dissolved in 30 mlCH 2CI2 and washed with 3 portions of water: The organic phase was then dried over sodium sulfate and the solvent evaporated. The crude residue was purified by elution through a silica gel column using ethyl acetate/hexane (3:7 v/v) as eluent to give 0.25 g (35"10) of 13 as a yellow oil.
Method G: 5-[7-[(adamantan-1-yl) 
oxy]heptyl]-3-methylisoxazole (18)
A mixture of 1-adamantanol (0.46 g, 3.0 mmol) and sodamide (0.14g, 3.6 mmol) in 15 ml anhydrous toluene was refluxed under nitrogen for 2.5 h. 5a was added and the mixture heated to reflux for 21 h. The work-up and purification was the same as for Method F. 0.20g (20%) of 18 was obtained as a yellow oil.
Using Methods 0, E, F and G, compounds 7-45 as indicated in Table 2 were prepared. Physical data for 7-45 is compiled in Table 6 .
